These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8466481)

  • 21. Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments.
    Simpson MM; Ballesteros JA; Chiappa V; Chen J; Suehiro M; Hartman DS; Godel T; Snyder LA; Sakmar TP; Javitch JA
    Mol Pharmacol; 1999 Dec; 56(6):1116-26. PubMed ID: 10570038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of residues important for ligand binding to the human 5-hydroxytryptamine1A serotonin receptor.
    Chanda PK; Minchin MC; Davis AR; Greenberg L; Reilly Y; McGregor WH; Bhat R; Lubeck MD; Mizutani S; Hung PP
    Mol Pharmacol; 1993 Apr; 43(4):516-20. PubMed ID: 8474430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine receptor microdomains involved in molecular recognition and the regulation of drug affinity and function.
    Floresca CZ; Schetz JA
    J Recept Signal Transduct Res; 2004 Aug; 24(3):207-39. PubMed ID: 15521362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine D1 receptors of the calf parathyroid gland: identification and characterization.
    Niznik HB; Fogel EL; Chen CJ; Congo D; Brown EM; Seeman P
    Mol Pharmacol; 1988 Jul; 34(1):29-36. PubMed ID: 2839763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constitutive activities and inverse agonism in dopamine receptors.
    Zhang B; Albaker A; Plouffe B; Lefebvre C; Tiberi M
    Adv Pharmacol; 2014; 70():175-214. PubMed ID: 24931197
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states.
    Leff SE; Hamblin MW; Creese I
    Mol Pharmacol; 1985 Feb; 27(2):171-83. PubMed ID: 3969066
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of the extracellular amino terminus and first membrane-spanning helix of dopamine D1 and D5 receptors in shaping ligand selectivity and efficacy.
    D'Aoust JP; Tiberi M
    Cell Signal; 2010 Jan; 22(1):106-16. PubMed ID: 19786093
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
    Hess EJ; Battaglia G; Norman AB; Creese I
    Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydrophobic residues of the D2 dopamine receptor are important for binding and signal transduction.
    Cho W; Taylor LP; Mansour A; Akil H
    J Neurochem; 1995 Nov; 65(5):2105-15. PubMed ID: 7595496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.
    Malmberg A; Nordvall G; Johansson AM; Mohell N; Hacksell U
    Mol Pharmacol; 1994 Aug; 46(2):299-312. PubMed ID: 8078492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
    Dautzenberg FM; Wille S
    Regul Pept; 2004 May; 118(3):165-73. PubMed ID: 15003833
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    Seeman P; Niznik HB; Guan HC; Booth G; Ulpian C
    Proc Natl Acad Sci U S A; 1989 Dec; 86(24):10156-60. PubMed ID: 2574862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cysteine at position 217 in the intracellular loop 1 plays a critical role in human PTH receptor type 1 membrane translocation and function.
    Thomas BE; Wittelsberger A; Woznica I; Hsieh MY; Monaghan P; Lee BK; Rosenblatt M
    J Bone Miner Res; 2007 Apr; 22(4):609-16. PubMed ID: 17227205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Site-directed mutagenesis of the gerbil and human angiotensin II AT(1) receptors identifies amino acid residues attributable to the binding affinity for the nonpeptidic antagonist losartan.
    Hoe KL; Saavedra JM
    Mol Pharmacol; 2002 Jun; 61(6):1404-15. PubMed ID: 12021402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonconserved residues in the second transmembrane-spanning domain of the D(4) dopamine receptor are molecular determinants of D(4)-selective pharmacology.
    Schetz JA; Benjamin PS; Sibley DR
    Mol Pharmacol; 2000 Jan; 57(1):144-52. PubMed ID: 10617689
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High affinity agonist binding to the dopamine D3 receptor: chimeric receptors delineate a role for intracellular domains.
    Robinson SW; Jarvie KR; Caron MG
    Mol Pharmacol; 1994 Aug; 46(2):352-6. PubMed ID: 7915820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dependence of agonist activation on a conserved apolar residue in the third intracellular loop of the AT1 angiotensin receptor.
    Hunyady L; Zhang M; Jagadeesh G; Bor M; Balla T; Catt KJ
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10040-5. PubMed ID: 8816747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth of cultured human cerebral meningiomas is inhibited by dopaminergic agents. Presence of high affinity dopamine-D1 receptors.
    Schrell UM; Fahlbusch R; Adams EF; Nomikos P; Reif M
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1669-71. PubMed ID: 1699967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.